GOEV vs HROW
GOEV (GOEV) versus Harrow Health Inc (HROW) — a side-by-side from cached financials, not a winner call.
GOEV (GOEV) common stock.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
GOEV does not have a complete income-statement cache yet.
Latest reported HROW revenue for 2024-12-31 was $199.6M. Net income was -$17.5M. Revenue was up 53.3% from 2023-12-31 to 2024-12-31. HROW currently screens at market cap $1.28B.
HROW currently screens at market cap $1.28B.
Not investment advice. Open the GOEV and HROW stock pages for the full models.
Not investment advice.